The structural homeostasis of the cochlear hair cell membrane is critical for all aspects of sensory transduction, but the regulation of its maintenance is not well understood. In this report, we analyzed the cochlear hair cells of mice with specific deletion of myosin light chain kinase (MLCK) in inner hair cells. MLCK-deficient mice showed impaired hearing, with a 5-to 14-dB rise in the auditory brainstem response (ABR) thresholds to clicks and tones of different frequencies and a significant decrease in the amplitude of the ABR waves. The mutant inner hair cells produced several ball-like structures around the hair bundles in vivo, indicating impaired membrane stability. Inner hair cells isolated from the knockout mice consistently displayed less resistance to hypoosmotic solution and less membrane F-actin. Myosin light-chain phosphorylation was also reduced in the mutated inner hair cells. Our results suggest that MLCK is necessary for maintaining the membrane stability of inner hair cells.
Introduction
Hearing is achieved through multiple steps; acoustic stimuli are received through the inner hair cells (IHCs) and outer hair cells (OHCs) in the organ of Corti, converted into electric signals, and then transmitted to the central nervous system [1] . These mechano-chemical and mechano-electrical transductions are performed by both cellular components and extracellular structures, and they involve many molecules in the inner ear, such as stretch-activated ion channels, caveolae, integrins, cadherins, growth factor receptors, myosin motors, cytoskeletal filaments, nuclei, extracellular matrix, and numerous other structures and signaling molecules [2] . The maintenance of membrane structure and the functional homeostasis of the cochlear cells are thus essential for these processes.
As critical sensors, hair cells function in signal transduction through apical hair bundles as well as somatic contractility and membrane machineries [2, 3, 4] . These cellular structures are important for the homeostasis of the cochlear hair cells and are highly regulated by cytoskeletal factors, including myosin motors, F-actin bundle proteins and F-actin crosslinking proteins [3, 5, 6] . Mutations in these proteins give rise to various types of hearing loss [7, 8, 9, 10] . It has been documented that several syndromic and non-syndromic types of hearing loss are caused by mutations of the myosin II genes, such as the p.R702H, p.R702C and p.R705H mutations in myosin heavy-chain 9 (MYH9) [11, 12, 13, 14] and the p.S7X, p.S120L, p.G376C and p.R726S mutations in MYH14 [15, 16] . Furthermore, recent reports have suggested that myosin II plays an important role in the development of the inner ear [17] . Therefore, similarly to other myosin motors, myosin II is thought to be important for hearing, but the underlying mechanism remains poorly understood. The activity of the myosin II MgATPase may be regulated by myosin light-chain kinase (MLCK) through the phosphorylation of the myosin regulatory light-chain (RLC), leading to the modulation of multiple physiological processes [18] . We therefore speculated that MLCK might also play an important part in hearing.
MLCK has been implicated in regulating the contraction of smooth muscle and many important physiological processes, including cell migration, neurite growth, cytokinesis, cytoskeletal organization, platelet shape changes, secretion, and transepithelial permeability, through its phosphorylation of the myosin regulatory light-chain and through its non-kinase activities [18] . The smooth muscle Mylk locus has been shown to express three independent transcripts, including short Mylk, long Mylk and telokin, by alternative promoters [18, 19, 20] . Short MLCK has a catalytic core, a regulatory segment, three immunoglobulin (Ig)-like modules, a fibronectin module, a PEVK repeat-rich region, and a 3DFRXXL F-actin-binding motif [21, 22] . Long MLCK is identical to short MLCK but also contains a unique N-terminal extension of ,900 residues. This extension region contains two Iglike regions, four Ig-like regions and two DFRXXL motifs [23] . Several studies have suggested that the kinase activity of MLCK mediates important changes in cytoskeleton organization through RLC phosphorylation [24, 25, 26, 27, 28] . Several studies have also suggested that these non-kinase regions have versatile functions in cytoskeleton reorganization [23, 29] . In the present study, we found that hair cells expressed short MLCK, implying that MLCK might function in hearing. To investigate the function and regulatory mechanism of MLCK in hair cells, we analyzed an animal model with a specific deletion of MLCK in the IHCs and found that MLCK functioned in the membrane of these cells.
Materials and Methods
All experiments were conducted in accordance with the guidelines set by the Animal Care and Use Committee of the Model Animal Research Center of Nanjing University (Nanjing, China) (permit number AP#MZ3).
Generation of knockout mice with a deletion of Mylk in IHC
Floxed Mylk mice (Mylk flox/flox ) in a congenic background (B6:129) were crossed with IHC-Cre transgenic mice [28, 30] . Because Cre driven by a prestin enhancer element is expressed in the IHCs beginning at postnatal day 14 [30] , the resultant mice (Mylk flox/flox :IHC-Cre; or MLCK IKO ) lacked MLCK in the IHCs. The littermates of the MLCK IKO mice (Mylk flox/+ :IHC-Cre) were used as controls (CTR). These mice were specific pathogen-free (SPF) and were maintained in standard animal rooms of the National Resource Center for Mutant Mice (NRCMM) of China.
ABR recordings
Mice were anesthetized by intraperitoneal injection with Avertin at an initial dose of 500 mg/kg body weight, and the anesthesia was maintained with a half-dose delivered every 20 min. The ABR waveforms were recorded with subcutaneous needle electrodes at the vertex (active), the posterior bulla region of the right ear (reference), and the tip of the nose (ground) in a single-walled, sound-proof booth. An outlay trumpet was placed 3 cm in front of the nasal tip. Click and tone pips of 8, 16 and 32 kHz were generated using an evoked generation workstation system III (Tucker Davis Technologies Incorporated, Gainesville, FL, USA) powered by SigGen32 software. The response was averaged (n = 1024) and displayed from 110 dB to 0 dB, decreasing in 5 dB steps. The threshold was determined in each series of ABR waveforms as the lowest intensity that produced at least two clearly visible waves. All of the mice were allowed to recover after testing using a warm pad at 37uC.
Western blot analyses
Western blot analyses were undertaken for the measurement of MLCK in the cochleae [28, 31, 32] . Briefly, the basilar membrane, including the hair cells, was isolated from postnatal mice (6-8 weeks) . This tissue was frozen quickly in lysis buffer containing 20 mM Tris/HCl (pH 7.4), 50 mM NaCl, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride and 10 mg/L aprotinin (Sigma-Aldrich, St Louis, MO, USA). After thorough homogenization, the sample was incubated on ice for an extra 30 min. The protein samples were prepared by boiling with loading buffer, followed by centrifugation. The protein concentration was measured using a bicinchoninic acid (BCA) protein assay (BioRad, Hercules, CA, USA). Equal amounts of protein were loaded for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer to a nitrocellulose membrane. The membrane was probed with a monoclonal antibody to MLCK (K36, Sigma-Aldrich, St Louis, MO, USA) followed by a secondary antibody. The MLCK signal was visualized by incubation with the Super Signal West Dura substrate (Pierce, Thermo, Rockford, USA) followed by exposure to film.
Cochlear whole-mount in situ hybridization
The digoxigenin-labeled Mylk mRNA riboprobe (554 nt) used for the whole-mount in situ hybridization was prepared by in-vitro transcription from a cDNA fragment using a MAXIscriptH In Vitro Transcription kit (Ambion, Applied Biosystems, TX, USA) according to the manufacturer's instructions, except that we synthesized the probe with 1.5 hours of extension at 37uC. The cDNA fragment cloned into the pBluescript KS+ plasmid vector (Stratagene, Agilent Technologies, CA, USA) was amplified from cDNA templates that were generated from mouse whole-embryo total RNA (Mylk mRNA accession number: BC058610) by reverse transcription using the following primers: EcoRI, forward, 59-GAATTCGCAAGTGAAGCCAAAGACCA-39; HindIII, reverse, 59-AAGCTT CCTGCCCTTTCTTACAGTTC-39. The mouse cochleae were fixed in 4% paraformaldehyde overnight at 4uC. They were dehydrated through a graded methanol series and stored at 220uC. Cochlear whole-mount in situ hybridization was conducted as described by Judice [33] with a modified hybridization buffer containing 50% (v/v) deionized formamide, 56 SSC20, yeast tRNA (0.3 mg/ml), heparin (0.1 mg/ml), CHAPS (1 mg/ml), EDTA (5 mM), Ficoll-400 (0.2 mg/ml), PVP (0.2 mg/ml), and BSA (0.2 mg/ml).
Genotyping of isolated hair cells
Mouse IHCs and OHCs were isolated from the mouse cochleae based on a reported method for the isolation of gerbil IHCs [34] . The isolated hair cells were genotyped using a polymerase chain reaction (PCR) assay, after which the template DNA was extracted by the salting-out method. The PCR primer set for the left homologous arm was (a) 59-TAGTGCGAGTGTCACTGTTG-39; the primer set for the right homologous arm was (b) 59-CCCCATGATTTGCCTCTAGT-39.
Histopathology
Mice were sacrificed with an overdose of anesthesia, and the acoustic capsule was removed. The cochleae were dissected out and infused with 4% paraformaldehyde in phosphate-buffered solution (PBS) through an open window over the cochlear apical turn. Decalcification was performed with 10% (W/V) ethylenediamine tetra-acetic acid (EDTA) for 5 days and followed by a standard histology examination. Briefly, the specimens were dehydrated in a graded series of ethanol solutions and subsequently embedded in paraffin. Sections were cut at 7-cm thickness and mounted onto positively charged slides. Standard hematoxylin and eosin (H&E) staining was conducted.
Electron microscopy analyses
Mice were anesthetized with an overdose of Avertin. They were perfused with PBS followed by fixation with 2.5% glutaraldehyde in PBS. The cochleae were selected and post-fixed in 2.5% glutaraldehyde in PBS at 4uC for 4-6 h, followed by decalcification. For scanning electron microscopy (SEM), the surrounding bone, stria vascularis, and tectorial membrane were removed. These tissues were fixed in 1% osmium tetroxide, dehydrated, and critical point-dried. The samples were then mounted on stubs and sputter-coated with gold. Images were collected with an S-3000 N scanning electron microscope (Hitachi, Tokyo, Japan) at 15 kV. For transmission electron microscopy (TEM), the samples were post-fixed in 1% osmium tetroxide, dehydrated, infiltrated, and polymerized in araldite. Ultrathin sections were post-stained and examined using a Hitachi-7650 transmission electron microscope (Hitachi Software Engineering, Yokohama, Japan).
Hypoosmotic assay
IHCs were isolated from mouse cochleae based on a reported method for the isolation of gerbil IHCs [34] . An accessory pipette (diameter, 50-60 mm) fabricated from a 3-mm thin-walled glass tube was used to manipulate the IHCs. The isolated IHCs were transferred into 20 mL isosmotic D-Hank's solution containing NaCl (136.9 mM), KCl (5.4 mM), Na 2 HPO 4 (0.3 mM), NaHCO 3 (4.2 mM), and KH 2 PO 4 (0.4 mM) at pH 7.2, adjusted to 300 mOsm. The cell shape in isosmotic solution was imaged using a Leica confocal laser scanning microscope (Leica, HD, GER). Subsequently, 40 ml of distilled water was carefully added onto the edge of the water bead without moving the cell. Cell images were obtained 10 min after this hypoosmotic treatment. The cell size was analyzed with the ImageJ software (http://imagejdev.org/ downloads). The cell volume was calculated using the following formula: V = 4/3pr 3 (V: volume; r: radius of the cell).
Immunofluorescence assay for cross-sections of the Corti's organ and inner ear sensory epithelia
To isolate the basilar membrane, the cochleae were removed and infused with 4% paraformaldehyde in PBS through the round window followed by post-fixation with the same buffer at 4uC for 3 h. After decalcification in 10% EDTA at room temperature overnight, the Corti sensory epithelia was dissected from the soft cochlea. Then, the cochleae were dissected, fixed in 4% paraformaldehyde overnight, decalcified with 10% EDTA at room temperature for 5 days, dehydrated through an ethanol gradient, embedded in paraffin and sectioned. The immunohistochemical analysis of the sections was performed after antigen retrieval by autoclaving. The sensory epithelia and sections were permeabilized with 0.5% Triton X-100 in PBS for 20 min and washed three times with PBS. Nonspecific binding was blocked by incubation with PBS containing 5% goat serum, 1% BSA, and 0.1% Triton X-100 for 1 h at room temperature. The tissues were incubated with primary antibody overnight at 4uC and washed three times with 0.1% Tween in PBS, followed by incubation with secondary antibody for 1.5 hours at room temperature. Anti-MLCK (K36, 1:200, Sigma-Aldrich, St Louis, MO, USA), antiphospho myosin light-chain 2 (Ser 19) (1:150 dilution; Cell Signaling, Cell Signaling Technology, BSN, USA) and antimyosin VII (1:200 dilution, Santa Cruz Biotechnology, CA, USA) were used as primary antibodies. The specificity of the K36 anti-MLCK antibody for immunofluorescence analysis was tested in MLCK-deficient smooth muscle, as we previously reported [28, 31, 35] . The smooth muscles from Mylk flox/flox ; SM22CreERT2 mice that received tamoxifen treatment did not stain with MLCK, whereas a clear MLCK signal was observed in control airway [31] , intestinal [28] and vascular smooth muscles [35] . Reports from other labs also suggest that the K36 antibody works well for immunostaining [36, 37] . Alexa Fluor 488-conjugated goat antirabbit IgG and Alexa Fluor 555-conjugated goat anti-mouse or anti-rabbit IgG were used as the secondary antibodies (Molecular Probes, Carlsbad, CA, USA). The specificities of the secondary antibodies were tested by comparison experiments with or without primary antibodies. F-actin was labeled by Alexa Fluor 488-conjugated phalloidin (Invitrogen, CA, USA). Topro dye (Invitrogen, CA, USA) was used to stain the nucleus. The immunofluorescence signals were examined under a Leica confocal microscope.
Data analysis
The data are represented as the means 6 S.E. Significant differences between groups were determined by Student's t-test.
Results

MLCK expression in the cochleae
MLCK is believed to be expressed ubiquitously, but its expression profile in the inner ear has not been documented. To measure MLCK expression in the inner ear, we conducted western blotting of the MLCK protein and in situ hybridization of the Mylk mRNA. The 108-kD MLCK protein (short MLCK) was detected clearly in the cochlear basilar membrane, but the 220-kD MLCK isoform (long MLCK) was not. Western blotting of the basilar membrane also supported this conclusion [ Fig. 1A ]. However, a minor deletion also occurred in the OHCs. Such non-specific leakage is unlikely to have affected the IHC phenotype because no phenotype was observed upon the deletion of MLCK in the OHCs (our unpublished data).
MLCK-deficient mice display an elevation of the hearing threshold
Control (CTR) and MLCK IKO mice (age, 4-6 months) were subjected to ABR waveform measurement. The ABR waveforms in response to clicks or tones at different intensities contained at least four distinct peaks (waves I-IV) [Fig. 2C ]. These peaks corresponded to cochlear activity (wave I) and neural activity (waves II-IV). Hearing function was evaluated based on the ABR thresholds, frequency dependency, and wave amplitude. Fig. 2D ]. In light of the hypothesis that the sensitivity to different frequencies of sound varies with the region of the hearing epithelia [38] , this result implied that the IHCs in a wide area were affected. Further analyses of the waveforms showed that the wave-I amplitudes on 60 dB, 50 dB and 40 dB in response to a tone (16 kHz) decreased by 7.75 mV on average, but the wave I/wave II ratio did not change (p.0.05) [Fig. 3 ]. This result suggested impairment in the proximal inner ear but no effect on central regulation. This featured pathology implies that such a phenotype might be unlikely to be attributed to the non-specific expression of Cre in the cerebellum, testis and other tissues of IHC-Cre mice [30] .
The deletion of MLCK led to the deformation of IHCs through the generation of a ball-like structure
To examine the histological structure of the organ of Corti, cochlear slides were stained with H&E and observed under light microscopy. In the knockout mice, the cochlear histology was normal with respect to the morphologies of the IHCs, OHCs, Hensen's cells and other cells around the organ of Corti [Fig. 4 ]. TEM analyses showed that the mutant IHCs had normal nuclei, cellular organelles and tight junctions. A careful examination of the cuticular plate and hair stereocilia showed a normal morphology and electronic density in these structures. Interestingly, several of the mutant IHCs produced ''bubbles'' at the top of the cuticular plate and in connection with the cytoplasm and membrane structure [ Fig. 5 ]. SEM examination revealed ball-like structures around the IHC stereocilia in approximately 85% of the mutant IHCs [Fig. 6 ]. The IHCs from younger (,6 weeks) knockout mice showed a lower formation frequency (,30%). The diameters of these ball-like structures ranged from 1.21 mm to 3.76 mm (mean, 1.97 mm). The ball-like structures were not observed in CTR cochleae. Our results suggested that these balllike structures were produced by the mutated inner hair cells.
MLCK-deficient IHCs were sensitive to hypoosmotic treatment
Changes in the volume of hair cells is important for hearing sensitivity [39, 40] , and the cell volume is primarily regulated by membrane tethering and cytoskeleton organization [41] . The results of our morphological analyses led us to speculate that the ball-like structures might be formed by an altered membrane tether force. To test this hypothesis, we treated isolated fresh IHCs with 30% physiologic solution (0.3% NaCl). After treatment, the volume of the IHCs from mutant mice increased significantly, from 722628 mm 3 (n = 4) to 13816112 mm 3 (n = 4) (P,0.01); the volume of the CTR IHCs also increased significantly, from 742644 mm 3 (n = 4) to 10246107 mm 3 (n = 4) (P,0.05). However, the relative increase in the volume of the MLCK-deficient IHCs was significantly higher than that of the CTR IHCs (1.9160.10 vs 1.3860.11, P,0.01). To verify this effect in the mutant IHCs, we conducted the same experiment using hypoosmotic glucose buffer. A similar result was obtained (data not shown). To exclude the possibility of injury to the IHC membrane from mechanical separation, we subjected an IHC cell mass to hypoosmotic treatment, and similar results were obtained [ Fig. 7 ]. This finding suggested that the deletion of MLCK caused increased sensitivity to hypoosmotic solution, and the MLCKdeficient IHCs showed a low membrane tension compared with control samples. To rule out the possible effects of alteration of the ion channels responsible for hypoosmotic treatment after MLCK deletion, we measured the expression of the Na + -K + -ATPase gene, an important pump for fluid homeostasis in the inner hair cells. The Na + -K + -ATPase protein level in either the mutant cochlear basilar membrane or MLCK-deficient smooth muscle tissue was comparable to that in control tissues [ Fig. 8 ]. Therefore, our results suggested that the deletion of MLCK did not affect Na
MLCK-deficient IHCs show reduced F-actin and RLC phosphorylation
The enriched F-actin mesh structure underneath the lipid layer is critical for the tethering tension or pliability of the cell membrane. To determine whether the F-actin density was altered in the MLCK IKO , we stained the inner ear cells with phalloidin. Most of the phalloidin signal was distributed around the IHC cell membrane and the button area. The CTR IHC had strong and continuous F-actin staining along its membrane structure. However, the F-actin staining in MLCK-deficient IHCs was weak and discontinuous [ Fig. 9A] . Quantitation of the relative F-actin density underneath the membrane at the lumbus of the cell showed that the mutant IHC had 64.43% of the density of the control (15.761.12 vs 24.4061.76, p,0.001) [Fig. 9, B and C] . The IHCs and OHCs displayed similar staining of myosin VII, a hair cell-specific structural protein in mice [ Fig. 9A ]. This result indicated that the polymerized F-actin underneath the IHC membrane was reduced after MLCK deletion.
MLCK is a dedicated kinase for myosin light-chain phosphorylation. In addition to its central role in smooth-muscle contraction [18, 28] , RLC phosphorylation is also involved in various cell processes [18] . There is evidence that the phosphorylation of the myosin light-chain enhances the formation of polymerized F-actin [42] . We therefore measured RLC phosphorylation in IHCs by staining for phosphorylated RLC with a specific antibody and quantifying its relative staining density over myosin VII with a modified ImageJ software [43] . In MLCK 
Discussion
Hearing loss is one of the most common sensory deficits in humans, and .50% of congenital cases of hearing loss are caused by genetic factors [44, 45, 46] . Linkage analyses have been used to identify the genetic correlations between genes and diseases [47] . However, investigations of hearing loss are limited because the inner ear is positioned deep within the temporal bones, and the physical examination of the human inner ear is possible only post studies. Moreover, hearing is a complex process that is coordinated by different cells in the organ of Corti, the neuronal system and other systems (e.g., the vascular system). Assessing the function of a ubiquitously expressed gene exclusively in IHCs is therefore difficult. To circumvent these difficulties, we specifically deleted the Mylk gene in inner hair cells by crossing floxed Mylk mice with transgenic mice that express Cre in the IHCs. Mice with successful ablation of Mylk are a useful model for elucidating MLCK function in IHCs.
Several cytoskeletal proteins, such as actin bundling proteins, non-conventional myosin molecules, cadherins, and Rho small GTPases, have been implicated in the function of hair cells [7, 9, 10, 11, 48, 49, 50, 51] . Mutations in these molecules cause structural abnormalities of the hair bundles, the cuticular plate, and stereocilial cross-linkage, resulting in the impairment of acoustic transduction [7, 9, 10, 11, 49] . MLCK is a potent regulator of cytoskeletal organization, so it is expected that this protein could play a critical role in the formation of these hearing structures. However, this study showed that MLCK deletion did not affect these structures in IHCs. This finding suggests that MLCK is not necessary for the formation of the stereocilia or the cuticular plate. However, the deletion of MLCK caused IHC membrane deformation, as indicated by the formation of ball-like structures, altered resistance to hypoosmotic treatment and reduced membrane F-actin staining. We thus suggest that MLCK might regulate the tether force of the IHC membrane, possibly through F-actin network formation, thereby regulating IHC membrane stability and proximal hearing transduction. This finding revealed a novel role for MLCK in acoustic transduction.
In OHCs, membrane homeostasis has important functions in hearing amplification. The underlying mechanism may involve ion channels, the membrane tether force and other membraneassociated events [51, 52] . Thus, hearing impairment due to MLCK deletion in IHCs may be caused by multiple factors. Among these possible factors, the formation of the ball-like structures may affect the rheology of the endolymphic fluid and hence inhibit the transduction of vibrations to the IHC hair bundles through this fluid [53] .
Based on the biochemical properties of MLCK, the regulation of membrane tension by MLCK might occur through several mechanisms. First, MLCK may strengthen the cell membrane through its non-kinase activities. The non-catalytic N-terminal extension of MLCK can bundle F-actin; it can also bind to myosin and interact with membrane proteins, thereby enhancing the cytoskeletal mesh structure underneath the lipid layers of the membrane [21, 22, 23, 54] . However, we did not detect the expression of long MLCK in IHCs. We therefore suggest that the N-terminal extension of MLCK might not be involved in the regulation of membrane tension. Second, MLCK might strengthen the cell membrane through its kinase activity. Increased myosin light-chain phosphorylation caused by the constitutive expression of active MLCK is correlated with increased cytoskeletal stiffness and reduced cell volume in Figure 10 . Immunohistochemistry of phospho-MLC2 and myosin VIIa in the basilar epithelium. In MLCK IKO mouse cochleae, the phospho-MLC2 signal (red) (asterisks and arrowhead) in 60-70% of IHCs was weaker than that of the CTR IHCs, whereas myosin VIIa staining (green) was similar in both CTR and MLCK IKO IHCs. The nuclei were stained (blue) with Topro. Scale bars: 10 mm. doi:10.1371/journal.pone.0034894.g010 fibroblasts in vitro [55] . As described in the present study, the deletion of MLCK in IHC cells led to decreased myosin lightchain phosphorylation and reduced amounts of F-actin throughout cells. This finding suggested that MLCK might regulate membrane F-actin through an RLC phosphorylationdependent mechanism. Short MLCK also contains three repeat motifs (DFRXXL) in its N-terminus, but it is unlikely that this protein has a critical function in the context of F-actin bundling because its bundling activity is much weaker [23] .
